The largest database of trusted experimental protocols

25 protocols using modular p800 analyzer

1

Metabolic Syndrome Diagnostic Criteria

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Metabolic Syndrome was defined by the Joint Interim Statement criteria as the co-occurrence of at least three out of the following five cardio-metabolic abnormalities: abdominal obesity, hypertension, hyperglycemia, hypertriglyceridemia, and low HDL-cholesterol. The detailed criteria and ethnic-specific cut-offs were described in
In both populations, waist circumference was measured halfway between the iliac crest and the lowest rib using a flexible steel tape measure to the nearest 0.1 cm (SECA Model 201, Seca Gmbh Co, Hamburg, Germany). Blood pressure was obtained by a digital sphygmomanometer at the left arm, at the upright sitting position, after 5 min rest (HEM-7200, Omron Healthcare Co, Ltd, Kyoto, Japan). The average of three measurements was used for analysis.
In the NEO Study, fasting plasma glucose was determined using a standard clinical chemistry method (Roche Modular P800 Analyzer, Roche Diagnostics, Mannheim, Germany). In the SUGARSPIN Study, glucose concentrations were measured with fingertip capillary blood test (BreezeÒ2 glucose meter, Bayer Health Care LLC, Basel, Switzerland). In both the NEO and SUGARSPIN studies, analyses of cholesterol and triglyceride concentrations were performed at the LUMC and determined based on enzymatic colorimetric methods (Roche Modular P800 Analyzer, Roche Diagnostics, Mannheim, Germany).
+ Open protocol
+ Expand
2

Biomarkers of Iron and Inflammation Status

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fasting blood samples were collected in vacuum tubes containing EDTA. All blood samples were separated into RBCs and serum, and stored at -80°C until being analyzed. Serum IL-1β, interferon (IFN)-γ, and IL-10 levels were determined by enzyme-linked immunosorbent assay (ELISA) kits (Procarta Cytokine Assay Kit; Affymetrix, Santa Clara, CA, USA) according to the manufacturer’s instructions. As an indicator of NO production, the nitrite concentration in the serum was determined with the Griess reagent (Sigma-Aldrich, St. Louis, MO, USA). Serum hepcidin was assessed by an ELISA (DRG International, Marburg, Germany). Serum ferritin was measured using a commercially available electrochemiluminescence immunoassay and was quantitated with a Roche Modular P800 analyzer (Mannheim, Germany). Serum iron and the total iron-binding capacity (TIBC) were measured by a ferrozine-based colorimetric method. The percent of transferrin saturation (%TS) was calculated by [serum iron/TIBC] x 100%. Serum testosterone was measured by an electrochemiluminescence immunoassay and was quantitated by a Modular analytics cobas E601 analyzer (Roche).
+ Open protocol
+ Expand
3

Kidney Tissue Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected and then centrifuged at room temperature. Blood urea nitrogen (BUN) and serum creatinine (Scr) levels in the serum were analysed by alkaline picrate method with Roche Modular P800 Analyzer (Roche, China). Portions of the left kidney tissues were fixed in 10% formalin. After gradient alcohol dehydration, the tissues were embedded in paraffin wax. Five‐μm‐thick sections were prepared and stained with haematoxylin and eosin(HE). Every sample was randomly cut into five histological sections. Histopathology examination was completed by using Nikon eclipse TE2000‐U Microscope.
+ Open protocol
+ Expand
4

Therapeutic Drug Monitoring Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood Tac concentrations were measured using the CMIA (chemiluminescent microparticle immunoassay) on the Architect instrument (Abbott Laboratories, Lake Forest, IL, USA) and CsA concentrations using the CEDIA PLUS assay (Cloned Enzyme Donor Immunoassay; Microgenics Corporation, Fremont, CA, USA) on a Modular P800 analyzer (Roche Diagnostics, Rotkreuz, Switzerland).
+ Open protocol
+ Expand
5

Fasting Serum Lipid Profile Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Venous blood samples were drawn between 8:00 a.m. and 10:00 a.m. after a 12-h fast. Serum aliquots were stored at room temperature and transported to the laboratory for testing on the same day. The fasting serum analyses of TC, TG, HDL-c, and LDL-c were measured by an enzymatic in vitro assay for direct quantification using a MODULAR P800 analyzer (Roche diagnostic, Switzerland). The intra- and inter-assay coefficient of variation to measure the parameters of total cholesterol, triglyceride, HDL-c, and LDL-c was less than 5%.
+ Open protocol
+ Expand
6

Serum Lipid and Lipoprotein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum samples were separated by centrifugation at 4 °C at 3500 g for 10 min. The routine laboratory parameters were determined from fresh sera with Cobas c501 analyzer (Roche Ltd. Mannheim, Germany). Total cholesterol levels were measured by using enzymatic, colorimetric tests (cholesterol oxidase-p-aminophenazone – GPOD-PAP; Modular P-800 analyzer; Roche/Hitachi). HDL cholesterol and LDL cholesterol levels were determined by a homogenous enzymatic, colorimetric assay (Roche HDL-C plus 3rd generation and Roche LDL-C plus 2nd generation, respectively). Apo A-I, ApoB and Lp(a) examinations were performed by immunoturbidimetric assays (Tina-quant apolipoprotein A-I ver. 2, Tina-quant apolipoprotein B ver. 2 and Tina-quant lipoprotein(a) ver. 2, respectively). The tests were performed according to the recommendation of the manufacturer. Sera were kept frozen at −70 °C for subsequent lipoprotein subfraction analysis and ELISA measurements.
+ Open protocol
+ Expand
7

Anthropometric and Metabolic Assessment in China

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anthropometric measurements, such as height, weight and WC, were conducted at the time of interview. Height was measured using a digital stadiometer with a fixed vertical backboard and an adjustable head piece. Weight was measured on a digital scale. At the end of a normal exhalation, WC was measured to the midpoint between the lower border of the rib cage and the iliac crest. Blood samples were drawn from the antecubital vein in the morning after a 12-h fasting. Laboratory tests included fasting plasma glucose (FPG), low- density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglyceride (TG) and insulin. FPG, LDL-C, HDL-C and TG were measured enzymatically using a MODULAR P800 Analyzer (Roche Diagnostics). Fasting serum insulin was measured by radioimmunoassay (XH-6010, Xi'an, China). These chemistries were measured at the laboratory of West China Hospital (Chengdu, China).
+ Open protocol
+ Expand
8

Ammonia Measurement in Plasma Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anthropometric measurements, including body mass index (BMI), and complete physical examination, were performed.
Peripheral blood samples for hepatic function assessment (transaminases, G-GT, alkaline phosphatase, bilirubin, albumin, complete blood count, coagulation tests, standard urine test, ammonia) were collected after 12-h fasting.
In particular, ammonia measurements were collected with EDTA tubes on venous samples. After immediate transport on ice to the laboratory, the samples were spun at 1,885 g for 10 min. Plasma ammonia concentration was measured on a Modular P800 analyzer (Roche, Roche Diagnostics, United States) using an enzymatic kinetic method with a final photometric measurement of produced NADPH at 340 nm (measuring range: 5.87–587 lmol/L; reference values from 11 to 50 lmol/L for women and 15–55 lmol/L for men, and intra- and interassay CV ≤ 8%) (22 (link)).
+ Open protocol
+ Expand
9

Preoperative Lipid Profile in ESCC

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 250 eligible patients with ESCC who underwent an esophagectomy at Shandong Cancer Hospital (Jinan, China) between April 2012 and October 2014 were included in the current study. The inclusion criteria were as follows: i) Patients were previously diagnosed with ESCC and received radical surgery; ii) TC, TG, HDL and LDL levels were examined 2–5 days prior to surgery between 6:00 and 8:00 a.m. using a Modular p800 analyzer (Roche Diagnostics, Basel, Switzerland); and iii) no drugs known to affect lipids, including statins, were taken by the patients. Exclusion criteria were as follows: i) History of another cancer type; ii) diabetes or another endocrine or metabolic disease that may influence serum lipid levels; and iii) cachexia [body mass index (BMI) <20 kg/m2].
+ Open protocol
+ Expand
10

Serum and Brain Biomarker Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum levels of total cholesterol (Chol), triglycerides (TG), alanine aminotransferase (ALT) and aspartate transaminase (AST) were determined using a Roche Modular P 800 Analyzer. Serum levels of diamine oxidase (DAO) (CUSABIO) and levels of Aβ40 and Aβ42 (Invitrogen) in the cerebral cortex were measured with ELISA kits.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!